Summary
Mecillinam was combined with ampicillin, carbenicillin, cloxacillin, and cefalexin and tested in vitro against clinical isolates of gram-negative bacteria. Synergy was frequently found, but test medium and inoculum size affected the extent of synergy. No synergy was obtained for combinations between mecillinam and penicillins against β-lactamase-producingHaemophilus influenzae orNeisseria gonorrhoeae, while combinations of clavulanic acid and penicillins showed strong synergism. Strains resistant to mecillinam were cultured in vitro, but the development of resistance was slower for the combinations than for mecillinam itself.
Zusammenfassung
Kombinationen von Mecillinam mit Ampicillin, Carbenicillin, Cloxacillin und Cephalexin wurden auf ihre Aktivität in vitro gegen in der Klinik isolierte, gramnegative Keime geprüft. Eine synergistische Wirkung zwischen den Komponenten wurde oft gefunden, ihr Ausmaß wurde aber von Nährmedium und Größe der Einsaat beeinflußt. Kombinationen von Mecillinam und Penizillinen zeigten keinen synergistischen Effekt gegen β-Laktamase-produzierendeHaemophilus influenzae undNeisseria gonorrhoeae. Dagegen wurde bei diesen Keimen ein starker Synergismus zwischen Klavulansäure und Penizillinen gefunden. Stämme, die resistent gegenüber Mecillinam sind, konnten in vitro gezüchtet werden, aber ihre Resistenzentwicklung erwies sich für die Mecillinam-Kombinationen langsamer als für Mecillinam selbst.
Similar content being viewed by others
Literature
Thomas, W. J., McReynolds, J. W., Mock, C. R., Bailey, D. W. Ampicillin-resistant. Haemophilus influenzae meningitis. Lancet 1 (1974) 313.
Williams, J. D., Kattan, S., Cavanagh, P. Penicillinase production by Haemophilus influenzae. Lancet 2 (1974) 103.
Phillips, I. β-lactamase-producing, penicillin-resistant gonococcus. Lancet 2 (1976) 656–657.
World Health Organisation:Neisseria gonorrhoeae producing β-lactamase. WHO Weekly Epidemiological Record No. 45 (1977).
Jawetz, E. The use of combinations of antimicrobial drugs. Annu. Rev. Pharmacol. 8 (1968) 151–170.
Klastersky, J., Jawetz, E. Clinical use of combinations of antibiotics. Hodder and Stoughton, London 1975.
Klastersky, J., Cappel, R., Daneau, D. Clinical significance ofin vitro synergism between antibiotics in gram-negative infections. Antimicrob. Agents Chemother. 2 (1972) 470–475.
Park, J. T., Burman, L. FL-1060: A new penicillin with a unique mode of action. Biochem. Biophys. Res. Commun. 51 (1973) 863–868.
Spratt, B. G. Distinct penicillin binding proteins involved in the division, elongation, and shape ofEscherichia coli K 12. Proc. Nat. Acad. Sci. USA 72 (1975) 2999–3003.
Tybring, L., Melchior, N. H. Mecillinam (FL 1060), a 6 β-amidinopenicillanic acid derivative: bacterial action and synergyin vitro. Antimicrob. Agents Chemother. 8 (1975) 271–276.
Baltimore, R. S., Klein, J. O., Wilcox, C., Finland, M. Synergy of mecillinam (FL 1060) with penicillins and cepholosporins againstProteus andKlebsiella with observations on combinations with other antibiotics and against other bacterial species. Antimicrob. Agents Chemother. 9 (1976) 701–705.
Neu, H. C. Synergy of mecillinam, 3 β-amidinopenicillanic acid derivate, combined with β-lactam antibiotics. Antimicrob. Agents Chemother. 10 (1976) 535–542.
Hamilton-Miller, J. M. T., Smith, J. T., Knox, R. Potentiation of penicillin action by inhibition of penicillinase. Nature 201 (1964) 867.
Sutherland, R., Batchelor, F. R. Synergistic activity of penicillins against penicillinase-producing gram-negative bacilli. Nature 201 (1964) 868.
Sabath, L. D., Abraham, E. P. Synergistic action of penicillins and cephalosporins againstPseudomonas pyocyanea. Nature 204 (1964) 1066–1069.
Sabath L. D. Combinations of penicillins and cephalosporins. In: Clinical use of combinations of antibiotics (Ed.:J. Klastersky, E. Jawetz), p. 71–87. Hodder and Stoughton, London 1975.
Reading, C., Cole, M. Clavulanic Acid: A beta-lactamase-inhibiting beta-lactam fromStreptomyces clavuligerus. Antimicrob. Agents Chemother. 11 (1977) 852–857.
Neu, H. C. Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria. Antimicrob. Agents Chemother. 9 (1976) 793–799.
Neu, H. C. Mecillinam — an amidino penicillin which acts synergistically with other β-lactam compounds. J. Antimicrob. Chemother. 3 Suppl. B (1977) 43–52.
Lund, F., Tybring, L. 6 β-Amidinopenicillanic acids — a new group of antibiotics. Nature [New Biol.] 236 (1972) 135–137.
Greenwood, D., O'Grady, F. FL 1060: A new beta-lactam antibiotic with novel properties. J. Clin. Pathol. 26 (1973) 1–6.
Greenwood, D., Linton Brooks, H., Gargan, R., O'Grady, F. Activity of FL 1060, a new β-lactam antibiotic, against urinary tract pathogens. J. Clin. Pathol. 27 (1974) 192–197.
Sjöberg, B., Bamberg, P., Ekström, B., Forsgren, U., Magni, L., Pring, B. G. Synergistic action in vitro between amidinopenicillanic acids and penicillins or cephalosporins. In Current chemotherapy: Proceedings of the 10th International Congress of chemotherapy (Eds.Siegenthaler, W., Lütthy, R.), Vol. 1, p. 432–434. American Society for Microbiology, Washington, D.C., 1978.
Tybring, L. Mecillinam (FL 1060), a β-amidinopenicillanic acid derivate: In vitro evaluation. Antimicrob. Agents Chemother. 8 (1975) 266–270.
Grunberg, E., Cleeland, R., Beskid, G., DeLorenzo, W. F. In vivo synergy between 6 β-amidinopenicillanic acid derivatives and other antibiotics. Antimicrob. Agents Chemother. 8 (1976) 589–594.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sjöberg, B., Ekström, B., Forsgren, U. et al. Synergy of mecillinam and clavulanic acid with other beta-lactam antibiotics. Infection 6 (Suppl 1), S17–S23 (1978). https://doi.org/10.1007/BF01646058
Issue Date:
DOI: https://doi.org/10.1007/BF01646058